Clinical Trial Update: Study of GS-0272 in Participants With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Gilead's GS-0272 is being studied in Phase 1 for rheumatoid arthritis, and the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GS-0272

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 1 | Status: ACTIVE_NOT_RECRUITING